These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18427520)

  • 21. Principles of pharmacologic correction of neurologic disorders in initial atherosclerotic encephalopathy.
    Man'kovsky NB; Minz AY
    Gerontology; 1988; 34(1-2):75-81. PubMed ID: 3384341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vincamine in the treatment of minor ictus (due to transient cerebral ischemia)].
    Franzini C; Ferrante P
    Minerva Med; 1974 Apr; 65(29):1631-41. PubMed ID: 4599654
    [No Abstract]   [Full Text] [Related]  

  • 23. [The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies].
    Bagoly E; Fehér G; Szapáry L
    Orv Hetil; 2007 Jul; 148(29):1353-8. PubMed ID: 17631470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
    Witzmann HK; Blechacz W
    Arzneimittelforschung; 1977; 27(6a):1238-47. PubMed ID: 332190
    [No Abstract]   [Full Text] [Related]  

  • 25. [A differential approach to cavinton and finoptin treatment of patients with circulatory encephalopathies].
    Burtsev EM; Shprakh VV; Savkov VS
    Ross Med Zh; 1992; (2):41-3. PubMed ID: 1643337
    [No Abstract]   [Full Text] [Related]  

  • 26. [An effect of vinpocetine (cavinton) on endothelium function in patients with chronic cerebral ischemia].
    Vaizova OE; Vengerovskiĭ AI; Alifirova VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():46-50. PubMed ID: 18196635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cavinton in the complex treatment of patients with chronic cerebrovascular insufficiency].
    Chukanova EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):35-9. PubMed ID: 19770831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of cerebral perfusion in a patient with chronic occlusive cerebrovascular disease using MRI perfusion-weighted imaging (PI)].
    Sasaki M; Komeichi T; Suzuki S; Saito K
    No Shinkei Geka; 1999 Dec; 27(12):1121-6. PubMed ID: 10629893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acetazolamide reactivity on SPECT correlates with PET parameters].
    Hirano T; Minematsu K; Hasegawa Y; Yamaguchi T
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1581. PubMed ID: 8752470
    [No Abstract]   [Full Text] [Related]  

  • 30. Cerebral blood flow in patients with chronic cerebrovascular disease: effect of acetyl L-carnitine.
    Postiglione A; Cicerano U; Soricelli A; De Chiara S; Gallotta G; Salvatore M; Mancini M
    Int J Clin Pharmacol Res; 1990; 10(1-2):129-32. PubMed ID: 2387659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determination of the regional cerebral blood flow by single photon emission CT(SPECT) with special reference to cerebrovascular diseases].
    Endo H; Kuroda K; Sugiyama H; Ejiri T; Kubo N; Kanaya H
    Nihon Rinsho; 1985 Feb; 43(2):309-17. PubMed ID: 3889408
    [No Abstract]   [Full Text] [Related]  

  • 32. Cavinton, a new cerebral vasodilator.
    Solti F
    Ther Hung; 1979; 27(1):15-6. PubMed ID: 494137
    [No Abstract]   [Full Text] [Related]  

  • 33. [SPECT follow-up of cerebral blood circulation after stroke].
    Pávics L; Katona E; Ambrus E; Heiner L; Morvay Z; Csernay L
    Orv Hetil; 1992 Aug; 133(31):1959-63. PubMed ID: 1495806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Serial angiographic evaluation of the effects of various vasoactive drugs on cerebral circulation in man].
    Bernini FP; Smaltino F
    Acta Neurol (Napoli); 1974 Mar; 29(2):170-84. PubMed ID: 4849693
    [No Abstract]   [Full Text] [Related]  

  • 35. [Angiographic study of the action of pervincamine on cerebral circulation].
    Baiano G; Elefante R; Granata F; Graziussi G
    Acta Neurol (Napoli); 1974 Mar; 29(2):185-9. PubMed ID: 4848048
    [No Abstract]   [Full Text] [Related]  

  • 36. [Role of psychophysiologic characteristics of patients in the efficacy of treatment with cavinton].
    Lil'in ET; Mar'in MI; Trubnikov VI; Vavilova TA
    Sov Med; 1983; (10):111-3. PubMed ID: 6658534
    [No Abstract]   [Full Text] [Related]  

  • 37. An overview of the contribution of regional cerebral blood flow studies in cerebrovascular disease: is there a role for single photon emission computed tomography?
    Hellman RS; Tikofsky RS
    Semin Nucl Med; 1990 Oct; 20(4):303-24. PubMed ID: 2237450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of sermion, Cavinton and trental in patients with cerebrovascular disorders].
    Lebedeva NV; Khrapova EV
    Sov Med; 1990; (1):60-3. PubMed ID: 2190329
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency].
    De Pergola E; Di Lorenzo L; De Pergola G
    G Clin Med; 1980 Aug; 61(8):628-42. PubMed ID: 7004986
    [No Abstract]   [Full Text] [Related]  

  • 40. [Patogenetic therapy of patients with diabetes mellitus type 2 and cerebral vascular insufficiency].
    Kamchatnov PR; Karalkin AV; Chugunov AV; Kabanov AA; Bassé DA; Mikhaĭlova NA; Umarova KhIa; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):18-23. PubMed ID: 18427536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.